Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731230) titled 'Biomodulator Patch for Subjective Tinnitus' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Murat Erinc
Condition:
Tinnitus
Hyperacusis
Intervention:
Device: Steady-State Coherent Biomodulator Patch (Antinitus)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 12, 2018
Target Sample Size: 91
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/st...